FOX 4: Kansas City Oncologist: New Cancer Drug Is ‘Just the Tip of the Iceberg’

The new FDA-approved drug, Rasonque, will improve survival rates in metastatic pancreatic cancer patients.

1 minute

The FDA approved a new pancreatic cancer drug on August 26, marking momentous step in the fight against cancer.

“This is something physicians have been waiting their entire lives," said Dr. Marc Roth, Saint Luke's medical director of gastrointestinal oncology.

FOX talked with Dr. Roth about what the dug means for advanced cancer patients and cancer research as a whole.